• Proven to slow CKD progression in type 2 diabetes
• Reduces risk of kidney failure & cardiovascular events
• Lower hyperkalemia risk than traditional steroidal MRAs
• Once-daily dosing with or without food
• First-in-class nsMRA backed by FIDELIO-DKD & FIGARO-DKD trials

1. Take one Finone 20mg tablet once daily at the same time, with or without food
2. Swallow whole with water – do not crush, chew, or divide
3. Continue your prescribed diabetes medications, diet, and lifestyle changes
4. Have regular blood tests for potassium and kidney function as advised
5. Attend follow-up appointments to monitor response and adjust dose if needed

Q1: How is Finone different from spironolactone or eplerenone?
A1: Finerenone is non-steroidal, more selective, and has lower risk of hyperkalemia & hormonal side effects.

Q2: When do doctors prescribe the 20mg strength?
A2: Usually when eGFR ≥25 and serum potassium ≤5.0 mmol/L – your doctor chooses 10mg or 20mg based on labs.

Q3: How soon does kidney protection start?
A3: Benefits on kidney and heart outcomes seen within months; full effect builds over years.

Q4: Can I take potassium supplements with Finone?
A4: Generally avoided – discuss with your doctor as hyperkalemia risk increases.

Q5: Is Finone a blood pressure tablet?
A5: It lowers BP slightly but is mainly prescribed for kidney & heart protection in CKD + type 2 diabetes.

• Not for patients with severe liver disease (Child-Pugh C) or eGFR <25 mL/min/1.73m²
• Monitor serum potassium regularly – risk of hyperkalemia (especially with potassium-sparing drugs)
• Avoid strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) – may increase Finerenone levels
• Use caution with moderate CYP3A4 inhibitors (dose adjustment to 10mg may be needed)
• Not recommended during pregnancy or breastfeeding
• Store below 30°C; keep away from children